DK0486536T3 - Antivirale midler midler indeholdende sulfoquinovosylglycerolderivater og analoger deraf - Google Patents

Antivirale midler midler indeholdende sulfoquinovosylglycerolderivater og analoger deraf

Info

Publication number
DK0486536T3
DK0486536T3 DK90911686.5T DK90911686T DK0486536T3 DK 0486536 T3 DK0486536 T3 DK 0486536T3 DK 90911686 T DK90911686 T DK 90911686T DK 0486536 T3 DK0486536 T3 DK 0486536T3
Authority
DK
Denmark
Prior art keywords
hiv
sulfoquinovosylglycerol
analogs
derivatives
antiviral agents
Prior art date
Application number
DK90911686.5T
Other languages
Danish (da)
English (en)
Inventor
Michael R Boyd
John H Ii Cardellina
Kenneth M Snader
Kirk R Gustafon
Gregory M L Patterson
James B Mcmahon
Owen S Weislow
Robert H Shoemaker
Kenneth D Paull
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0486536T3 publication Critical patent/DK0486536T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK90911686.5T 1989-08-15 1990-08-03 Antivirale midler midler indeholdende sulfoquinovosylglycerolderivater og analoger deraf DK0486536T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39378089A 1989-08-15 1989-08-15

Publications (1)

Publication Number Publication Date
DK0486536T3 true DK0486536T3 (da) 1995-04-10

Family

ID=23556218

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90911686.5T DK0486536T3 (da) 1989-08-15 1990-08-03 Antivirale midler midler indeholdende sulfoquinovosylglycerolderivater og analoger deraf

Country Status (9)

Country Link
EP (1) EP0486536B1 (de)
JP (1) JPH0747540B2 (de)
AT (1) ATE113210T1 (de)
AU (1) AU635057B2 (de)
CA (1) CA2064772A1 (de)
DE (1) DE69013688T2 (de)
DK (1) DK0486536T3 (de)
ES (1) ES2064748T3 (de)
WO (1) WO1991002521A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774094B1 (fr) * 1998-01-26 2001-04-13 Ifremer Procede de purification de sulfoquinovosyldiacylglycerol par chromatographie de partage centrifuge
JP3851461B2 (ja) 1998-09-04 2006-11-29 東洋水産株式会社 ピラノシドおよびその製造方法
US6518410B2 (en) 1999-02-26 2003-02-11 Toyo Suisan Kaisha, Ltd. Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments
WO2000052020A1 (fr) 1999-02-26 2000-09-08 Toyo Suisan Kaisha, Ltd. Nouveaux derives du et leur utilisation comme medicaments
EP1172107B1 (de) * 1999-02-26 2006-12-20 Toyo Suisan Kaisha, Ltd. Heilmittel die sulfopyranosylacylglycerolderivate enthalten
CA2362903C (en) * 1999-02-26 2006-06-13 Toyo Suisan Kaisha, Ltd. Novel sulfofucosylacylglycerol derivatives and use thereof as medicaments
CA2452530C (en) 2001-07-09 2008-11-18 Toyo Suisan Kaisha, Ltd. Novel immunosuppressive agent
FR2840318B1 (fr) * 2002-05-29 2004-12-03 Quoc Kiet Pham Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
FR2867475B1 (fr) * 2004-06-10 2006-09-22 Quoc Kiet Pham Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
EA016931B1 (ru) * 2007-07-20 2012-08-30 Тойо Суйсан Кайся, Лтд. Новое сульфированное соединение сахара и его применение в качестве лекарственного средства

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989003684A1 (fr) * 1987-10-30 1989-05-05 Chugai Seiyaku Kabushiki Kaisha Agent anti-vih

Also Published As

Publication number Publication date
EP0486536B1 (de) 1994-10-26
CA2064772A1 (en) 1991-02-16
AU635057B2 (en) 1993-03-11
ATE113210T1 (de) 1994-11-15
EP0486536A1 (de) 1992-05-27
AU6067990A (en) 1991-04-03
JPH0747540B2 (ja) 1995-05-24
DE69013688D1 (de) 1994-12-01
WO1991002521A1 (en) 1991-03-07
DE69013688T2 (de) 1995-05-18
EP0486536A4 (en) 1992-09-16
JPH05501105A (ja) 1993-03-04
ES2064748T3 (es) 1995-02-01

Similar Documents

Publication Publication Date Title
DK166277C (da) Anvendelse af pyridazinaminer til fremstilling af antivirale praeparater, pyridazinaminer til brug som antivirale midler, antivirale praeparater, pyridazinaminer og fremgangsmaade til fremstilling deraf
DK224286A (da) 2',3'-dideoxy-nucleosider
CA2081356A1 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n- acetyl neuraminic acid and their use as antiviral agents
FI832355L (fi) 9-(2-hydroxyetoximetyl)guanidin-derivat
DK602988D0 (da) Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
DE69013688D1 (de) Antivirale zusammensetzungen enthaltend sulfoquinovosylglycerolderivate und analoge davon.
NO970847D0 (no) 2-£amino-6-(cyklopropylamino)-9H-purin-9-yl|-2-cyklopenten-1-metanol-succinat som anti-virusmiddel
DK326586A (da) Antivirale pyrimidinforbindelser, farmaceutiske kompositioner indeholdende forbindelserne og kompositionernes fremstilling
ATE71840T1 (de) Virushemmende nukleosidmischung.
MC1930A1 (fr) Produit antiviral
SE8203856D0 (sv) Novel derivatives of guanine ii
US5596018A (en) Antiviral agents against aids-causing virus
DE68914809D1 (de) Antivirale Wirkstoffe.
ES8308335A1 (es) Un procedimiento para la preparacion de nuevos derivados de desoxiuridina.
DK410189D0 (da) Farmaceutisk praeparat til inhibering af infektion med vira, som fremkalder aids
ES2078380T3 (es) Oligofosfatos de accion antiviral.
Vogt et al. Effect of daily zidovudine (AZT) pulse-therapy on replication of human immunodeficiency virus type 1 and type 2 in vitro
GT198700077A (es) Un procedimiento de preparacion de una formulacion farmaceutica que comprende 3'-azido-3'desoxitimidina.